Inhibiting stress response protein YCK2 to overcome antifungal resistance

DISEASE CATEGORY: Infectious disease

INDICATION: Candida

A team led by Bright Angel Therapeutics Inc. co-founder Leah Cowen, and including fellow co-founder Luke Whitesell,

Read the full 226 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE